معرفی
Dr. Emily Behling is a Clinical Assistant Professor at Yale School of Medicine, affiliated with the Child Study Center. She specializes in child and adolescent psychiatry with a focus on neurodevelopmental disorders, particularly Tourette syndrome and ADHD. Her research emphasizes pharmacological interventions, meta-analyses, and evidence-based treatment strategies. Dr. Behling completed her MD at the University of Connecticut School of Medicine and a BS in Biology from the same institution.
Her work explores the efficacy and tolerability of medications for tic disorders and ADHD, with recent studies examining placebo responses in Tourette disorder trials and stimulant dosing strategies. Collaborations include Michael Bloch, Angeli Landeros-Weisenberger, and Adam Lombroso, among others.
Key research themes include comparative effectiveness of pharmacological treatments, drug safety profiling, and optimizing therapeutic approaches for pediatric populations. She has published in high-impact journals such as The Lancet Child & Adolescent Health and Molecular Psychiatry.
